Drugs Made In America Acquisition II Corp.（DMII）内部人交易：高管与董事近期交易
过去 18 个月，共有 6 位内部人为 Drugs Made In America Acquisition II Corp.（DMII）报告了 10 笔 Form 4 交易（最近一笔 2025-10-17）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2025-10-17 | Do Catherine | 董事 | 买入 | 100,000 | $0 |
| 2025-10-02 | Shulgan Myron W. | 董事 | 买入 | 100,000 | $0 |
| 2025-10-01 | Prasad Sridhar G. | 董事 | 买入 | 100,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | 10% 以上股东 | 买入 | 700,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | 10% 以上股东 | 卖出 | 400,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | 10% 以上股东 | 卖出 | 8.0M | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | 买入 | 700,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | 卖出 | 400,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | 卖出 | 8.0M | $0 |
| 2025-10-01 | Worman Glenn C. | CFO | 买入 | 100,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-10-17